Credit Suisse Ag Global Blood Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$32.4 - $68.18 $2.56 Million - $5.39 Million	78,996 Added 149.85%	131,712 $8.97 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $127,243 - $213,347	-5,706 Reduced 9.77%	52,716 $1.68 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $102,437 - $141,968	3,989 Added 7.33%	58,422 $2.02 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $50,148 - $81,083	-2,014 Reduced 3.57%	54,433 $1.59 Million
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $78,376 - $114,857	3,076 Added 5.76%	56,447 $1.44 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $359,948 - $481,484	-11,089 Reduced 17.2%	53,371 $1.87 Million
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $880,121 - $1.15 Million	-22,602 Reduced 25.96%	64,460 $2.63 Million
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $30,684 - $51,972	815 Added 0.94%	87,062 $3.77 Million
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $150,102 - $211,924	2,845 Added 3.41%	86,247 $4.76 Million
Q2 2020 Aug 12, 2020	BUY	$48.73 - $81.82 $1.26 Million - $2.11 Million	25,784 Added 44.75%	83,402 $5.27 Million
Q1 2020 May 13, 2020	SELL	$41.72 - $87.2 $1.06 Million - $2.21 Million	-25,364 Reduced 30.57%	57,618 $2.94 Million
Q4 2019 Feb 12, 2020	BUY	$45.7 - $81.86 $1.75 Million - $3.13 Million	38,258 Added 85.54%	82,982 $6.6 Million
Q3 2019 Nov 12, 2019	SELL	$45.35 - $57.91 $7.12 Million - $9.09 Million	-157,013 Reduced 77.83%	44,724 $2.17 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $8.68 Million - $10.4 Million	164,987 Added 448.94%	201,737 $10.6 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $5,478 - $7,326	-137 Reduced 0.37%	36,750 $1.94 Million
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $328,709 - $486,394	-10,422 Reduced 22.03%	36,887 $1.52 Million
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $184,718 - $248,397	-4,861 Reduced 9.32%	47,309 $1.8 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $175,736 - $227,731	-4,541 Reduced 8.01%	52,170 $2.36 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $796,474 - $1.33 Million	20,113 Added 54.96%	56,711 $2.74 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $2.31 Million - $3.55 Million	-77,647 Reduced 67.97%	36,598 $1.44 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $114,179 - $141,246	4,549 Added 4.15%	114,245 $3.55 Million
Q2 2017 Aug 14, 2017	BUY	N/A	109,696	109,696 $3 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account